NCT05012579View on ClinicalTrials.gov

Transcutaneous Afferent Patterned Stimulation (TAPS) for Reduction of Parkinson's Disease (PD) Related Action Tremor

NACompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

March 12, 2021

Study Completion Date

March 12, 2021

Conditions

Parkinson Disease

Interventions

DEVICE

Cala Device

transcutaneous afferent patterned stimulation (TAPS)

Trial Locations (1)

94010

Cala Clinic, Burlingame

Sponsors

Lead Sponsor

Cala Health, Inc.

All Listed Sponsors

lead

Cala Health, Inc.

INDUSTRY

NCT05012579 - Transcutaneous Afferent Patterned Stimulation (TAPS) for Reduction of Parkinson's Disease (PD) Related Action Tremor | Biotech Hunter | Biotech Hunter